<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
CRSP
Crispr Therapeutics
$
()


  • Crispr Therapeutics call volume above normal and directionally bullish

    4/18/2024 - 14:06pm
  • Crispr Therapeutics price target raised by $1 at Citi, here's why

    4/18/2024 - 05:57am
  • Cantor Fitzgerald biotech analysts hold an analyst/industry conference call

    3/14/2024 - 12:50pm
  • Cantor Fitzgerald biotech analysts hold an analyst/industry conference call

    3/14/2024 - 11:41am
  • Crispr Therapeutics proposes to elect Christian Rommel to board of directors

    3/13/2024 - 08:40am
  • Crispr Therapeutics price target raised by $17 at Mizuho, here's why

    3/6/2024 - 07:02am
  • Crispr Therapeutics call volume above normal and directionally bullish

    2/22/2024 - 10:25am
  • Crispr Therapeutics price target raised by $9 at RBC Capital, here's why

    2/22/2024 - 09:33am
  • Crispr Therapeutics price target raised by $15 at Wells Fargo, here's why

    2/22/2024 - 07:04am
  • Crispr Therapeutics price target raised by $19 at Barclays, here's why

    2/22/2024 - 05:31am
  • Crispr Therapeutics price target raised by $2 at Chardan, here's why

    2/21/2024 - 18:26pm
  • Fly Intel: Pre-market Movers

    2/21/2024 - 08:59am
  • Crispr Therapeutics reports Q4 EPS $1.10, consensus (7c)

    2/21/2024 - 07:34am
  • Crispr Therapeutics options imply 7.2% move in share price post-earnings

    2/20/2024 - 13:34pm
  • Crispr Therapeutics initiated with neutral view at Wolfe Research, here's why

    2/14/2024 - 19:16pm
dynamic_feed Breaking News